Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Spinnovation Introduces New Elemental and Trace Metals Analysis

Published: Tuesday, November 05, 2013
Last Updated: Tuesday, November 05, 2013
Bookmark and Share
New Elemental Analysis for cell culture media and raw materials.

To offer a more complete analysis platform for cell culture, Spinnovation has introduced new Elemental Analysis for cell culture media and raw materials.

Elemental Analysis uses Inductively Coupled Plasma-Optical Emission Spectroscopy (ICP-OES) to test samples for up to 30 elements and trace metals, at levels as low as parts per billion (ppb).

With this service Spinnovation enables customers to characterize raw materials and monitor the elements critical to cells, for maximum cell culture production yield and optimal performance.

Elemental Analysis is a flexible custom analysis service, tailored to clients’ needs. Each customer may select the elements to be monitored in groups of up to 25.

Elemental Analysis can be used to monitor both standard and trace level elements. Analysis is charged competitively on a pay-per-sample basis.

Moreover, Spinnovation provides quick turnaround, with results typically delivered within 10 business days. This new offering complements the analysis packages already available at Spinnovation to develop troubleshoot and monitor bioprocess, including Spedia-NMR™, vitamin analysis and different raw material profiling assays.

Frederic Girard, CEO of Spinnovation Analytical, said, “Elemental Analysis adds to our advanced cell culture analysis offering, by allowing customers to quickly assess levels of elements vital to cell growth in cultures and to troubleshoot bioprocess performance variability. Together with Spedia-NMR™ for upstream processing and Spedia-Predict™ for achieving optimal and consistent bio-manufacturing performance, Elemental Analysis will allow us to meet all the needs of customers in the biologics field.”


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Spinnovation Transfers its Entire Operation to Pivot Park
The new location has enabled Spinnovation to double the size of its facilities, to support the growth of its business.
Monday, January 13, 2014
CEO Frederic Girard Joins Fellow Industry Experts for a QbD Round Table
New article on quality by design is now available online.
Friday, August 16, 2013
Spinnovation Expands in to the US
Spinnovation collaborate with Quantum Tessera in Pennsylvania.
Tuesday, April 17, 2012
Scientific News
First Artificial Ribosome Designed
Researchers at the University of Illinois at Chicago and Northwestern University have engineered a tethered ribosome that works nearly as well as the authentic cellular component, or organelle, that produces all the proteins and enzymes within the cell.
Experimental MERS Vaccine Shows Promise in Animal Studies
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines.
Sweet Revenge Against Superbugs
A special type of synthetic sugar could be the latest weapon in the fight against superbugs.
Researchers Develop Vaccine that Protects Primates Against Ebola
A collaborative team from The University of Texas Medical Branch at Galveston and the National Institutes of Health have developed an inhalable vaccine that protects primates against Ebola.
Universal Flu Vaccine in the Works
A new study has demonstrated a potential strategy for developing a flu vaccine with potent, broad protection.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Ferring Bets on Bacteriophages to Treat Inflammatory Bowel Disease
Ferring Pharmaceuticals have annoucned that it will collaborate with Intralytix in the latest phase of its early stage development programme for a bacteriophage-based therapy for inflammatory bowel disease (IBD).
A Novel Drug to FIght Malaria
An international team of scientists has announced that a new compound to fight malaria is ready for human trials.
Ebola Vaccine Trial Begins in Senegal
A clinical trial to evaluate an Ebola vaccine has begun in Dakar, Senegal, after initial research started at the Jenner Institute, Oxford University.
New Cell Structure Finding Might Lead to Novel Cancer Therapies
University of Warwick scientists in the U.K. say they have discovered a cell structure which could help researchers understand why some cancers develop.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!